VTE Prophylaxis Dosing for Patients Post Lower Extremity Amputation

Recommended Prophylactic Options

The American College of Cardiology recommends unfractionated heparin (UFH) 5000 IU subcutaneously every 8 hours or enoxaparin 40 mg subcutaneously once daily until fully ambulatory or hospital discharge for patients post lower extremity amputation 1
UFH 5000 IU subcutaneously every 8 hours is preferred, especially in patients with cancer or high VTE risk, as it provides a more consistent anticoagulant effect compared to twice-daily dosing 1, 2
Enoxaparin 40 mg subcutaneously once daily is an effective alternative for VTE prophylaxis in patients post lower extremity amputation 1

For patients with renal impairment (creatinine clearance <30 mL/min), UFH is preferred as it's primarily metabolized by the liver, and if using enoxaparin, the dose should be reduced to 30 mg subcutaneously once daily 1, 3, 4
Fondaparinux is contraindicated in severe renal insufficiency (CrCl <30 mL/min) 5
For obese patients (BMI >30 kg/m²), consider intermediate doses of enoxaparin (40 mg subcutaneously every 12 hours) or weight-based dosing (0.5 mg/kg subcutaneously every 12 hours) 1

Continue prophylaxis until the patient is fully ambulatory or discharged from the hospital, with a minimum duration of 7-10 days recommended for surgical patients 1, 5

Routine monitoring of anti-Xa levels is not required for most patients on prophylactic doses, but platelet count monitoring every 2-3 days from day 4 to day 14 is recommended for patients with a risk of heparin-induced thrombocytopenia (HIT) of 1% or more 1, 6, 5
The risk of HIT with UFH may be as high as 5%, particularly in patients recuperating from orthopedic surgery 6, 5